CIK 0001124105 · Accelerated filer<br>Smaller reporting company
GYRE THERAPEUTICS, INC.
Sign in to watch- Ticker
- GYRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562020050
- Phone
- (858) 284-0115
- Business address
- 12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
- Former names
- CATALYST BIOSCIENCES, INC., TARGACEPT INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-27 | Ma Songjiang President | Sale 10b5-1 | −2,000 | $10.28 | $21K | 2,806,642 |
| 2025-05-27 | Zhang Ping Director | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2025-05-23 | Ma Songjiang President | Sale 10b5-1 | −182 | $10.24 | $2K | 2,808,642 |
| 2025-05-22 | Ma Songjiang President | Sale 10b5-1 | −2,000 | $10.97 | $22K | 2,808,824 |
| 2025-05-21 | Ma Songjiang President | Sale 10b5-1 | −2,000 | $10.83 | $22K | 2,810,824 |
| 2025-05-20 | Ma Songjiang President | Sale 10b5-1 | −2,000 | $11.25 | $23K | 2,812,824 |
| 2025-05-19 | Ma Songjiang President | Sale 10b5-1 | −2,000 | $11.11 | $22K | 2,814,824 |
| 2025-05-16 | Ma Songjiang President | Sale 10b5-1 | −2,000 | $11.31 | $23K | 2,816,824 |
| 2025-05-15 | Ma Songjiang President | Sale 10b5-1 | −2,000 | $10.68 | $21K | 2,818,824 |
| 2025-05-14 | Ma Songjiang President | Sale 10b5-1 | −20 | $11.30 | $226 | 2,820,824 |
| 2025-05-13 | Ma Songjiang President | Sale 10b5-1 | −2,000 | $11.37 | $23K | 2,820,844 |
| 2025-05-12 | Ma Songjiang President | Sale 10b5-1 | −2,000 | $10.56 | $21K | 2,822,844 |
| 2025-04-16 | Eastling Thomas Wilson Director | Option exercise | +15,000 | $6.93 | $104K | 15,000 |
| 2025-04-16 | Eastling Thomas Wilson Director | Option exercise · Stock Option (Right to Buy) | −15,000 | 299,652 | ||
| 2025-04-01 | Ye Weiguo Chief Operating Officer | Option exercise | +50,000 | $0.75 | $38K | 700,000 |
| 2025-04-01 | Ye Weiguo Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −50,000 | 965,115 | ||
| 2025-03-27 | Ye Weiguo Chief Operating Officer | Option exercise | +150,000 | $0.75 | $113K | 650,000 |
| 2025-03-27 | Ye Weiguo Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −150,000 | 1,015,115 | ||
| 2025-03-26 | Ye Weiguo Chief Operating Officer | Option exercise | +200,000 | $0.75 | $150K | 500,000 |
| 2025-03-26 | Ye Weiguo Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −200,000 | 1,165,115 |
Page 5 of 11 · 215 trades